20273 results for «»

Filter By

20273 results

PCR London Valves 2019: Programme highlights

Hands-on workshops, Learning sessions, LIVE demonstrations, keynote lectures and more are lined up for all of the Heart Valve Team in November!

TAVI in unusual clinical situations

19 Nov 2019 – From PCR London Valves 2019

Consult this session to discover various interesting cases, involving TAVI in unusual clinical situations, such as in long-term ventricular assist device supported patient, in pure aortic regurgitation and advanced liver and kidney failure, and more!

TAVI in unusual clinical situations

Prosthesis-patient mismatch following transcatheter aortic valve replacement with supra-annular and intra-annular prostheses

03 Dec 2019

The results of this study suggest that the use of self-expandable valves could help reduce the incidence of post-procedural PPM after TAVI, especially in the population with large body size...

Reviewer

Romain Didier
Souheib Feliachi

Reviewer

Souheib Feliachi
Prosthesis-patient mismatch following TAVR with supra-annular and intra-annular prostheses

Souheib Feliachi

Brest, France

Souheib Feliachi

PCR Webinars: a perfect complement to EuroPCR!

15 Sep 2025 - 15 Sep 2025

Discover several series of free 60-minute webinars on topics such as bifurcation, FFR and high-bleeding risk patients. Join live to question experts who are In The Lab or at the Round Table, or watch on replay all year long!
PCR Webinars

Irfan Bhat

Dehradun, India

Sivaramakrishnan Manoj

Mahmoud Traina

Abu Dhabi, United Arab Emirates

Femoral versus nonfemoral peripheral access for transcatheter aortic valve replacement

05 Dec 2019

Using the data from the national prospective French registry (FRANCE TAVI), this study compared the characteristics and outcomes of TAVR procedures according to whether they were performed through a femoral or a nonfemoral peripheral access.

Reviewer

Salvatore Brugaletta
Femoral vs nonfemoral peripheral access for transcatheter aortic valve replacement

Khaleel Syed Abdul Khadar

Salem, India

Reduced leaflet motion after transcatheter aortic-valve replacement

27 Nov 2019

The GALILEO-4D was a dedicated substudy that sought to evaluate the effect of oral anticoagulation with rivaroxaban on bioprosthetic aortic valve leaflet thickening and motion impairment.

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Antonio H. Frangieh

Reviewer

Antonio H. Frangieh
Reduced leaflet motion after transcatheter aortic-valve replacement

Reda Abuelatta

Medina, Saudi Arabia

Concetta Mammone

Verona, Italy

Concetta Mammone

Optimal strategy for antiplatelet therapy after endovascular revascularization for lower extremity peripheral artery disease

15 Jan 2020

The aim of this study was to examine the optimal strategy for antiplatelet therapy for patients with lower extremity peripheral artery disease (PAD) following endovascular repair

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Optimal strategy for antiplatelet therapy after endovascular revascularization for lower extremity peripheral artery disease

Ching Wei Lee

TAIPEI

Pierfrancesco Corvo

RAs Al Khaimah, United Arab Emirates

Mohamed Abdelwahab Adel

Cairo, Egypt

Ashraf Abdelsalam

Kuwait, Kuwait

A controlled trial of rivaroxaban after transcatheter aortic-valve replacement (GALILEO)

13 Dec 2019

The GALILEO trial was a randomized, open-label, event-driven, international, multicentre trial comparing two different preventive strategies for thromboembolic complications in patients who underwent successful TAVI and had not established indication for oral anticoagulation.

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Eduardo Bahena-López

Reviewer

Eduardo Bahena-López
A controlled trial of rivaroxaban after transcatheter aortic-valve replacement

Eduardo Bahena-López

Mexico City, Mexico

Eduardo Bahena-López
Didn’t find what you were looking for?